Haleon logo

Haleon

HLN | NYSE
Chart Builder DCF Calculator
$9.36
+$0.08 (+0.86%)
At close: Sep 21, 2026, 4:00 PM ET
$9.38
+$0.02 (+0.21%)
After-hours: Sep 21, 2026, 4:31 PM ET

Company Profile

Haleon plc is a significant global entity in the consumer healthcare sector, engaging in the entire process from scientific research and development to the production and worldwide distribution of various wellness goods. The company's reach extends across North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific region. Its diverse product portfolio encompasses therapeutic solutions for oral care, pain management, respiratory well-being, and digestive health, alongside a comprehensive range of vitamins, minerals, and other dietary supplements. Noteworthy brands within its collection include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. Established in 2021, the company was initially known as DRVW 2022 plc before officially changing its name to Haleon plc in February 2022. It is headquartered in Brentford, United Kingdom.

Key Executives

Name Position
Brian James McNamara Chief Executive Officer & Executive Director
Dawn Amanda Allen Chief Financial Officer & Director
Tamara Rogers Chief Marketing Officer
Adrian Charles Morris General Counsel
Bjorn Timelin Head of Strategy
Claire Dickson Chief Digital & Technology Officer
Filippo Lanzi President of EMEA & LatAm
Joanne Russell Head of Investor Relations
Keith Choy President of Asia Pacific
Line De Decker Chief Human Resources Officer

Latest SEC Filings

Date Type Title
Sep 01, 2026 6-K Filing
Aug 26, 2026 CERT Filing
Aug 21, 2026 8-A12B Filing
Aug 21, 2026 6-K Filing
Aug 19, 2026 6-K Filing
Aug 19, 2026 6-K Filing
Aug 17, 2026 6-K Filing
Aug 13, 2026 424B5 Filing
Aug 13, 2026 6-K Filing
Aug 13, 2026 FWP Filing
View All SEC Filings
Haleon
Haleon logo
Country United Kingdom
IPO Date Jul 24, 2022
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 24,535
CEO Brian James McNamara

Contact Details

The Heights Weybridge, SU KT13 0NY United Kingdom

Stock Details

Ticker Symbol HLN
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001900304
CUSIP Number 405552100
ISIN Number US4055521003
SIC Code 2844

© 2026 bestshares.com. All rights reserved.